Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Tiba Biotech LLC is active in the Biotechnology & Pharmaceuticals technology area. The company currently has 2 pending office actions. These actions are split between 2 distinct examiners, meaning no single examiner is handling more than one case. LIPPOLIS, ALEXANDRA ROSE is the busiest examiner for the company, with a total of 1 pending office action.
The prosecution is spread across 2 distinct art units, which corresponds to the 2 distinct examiners involved. This distribution indicates that the company's 2 pending office actions are being processed in different technical or administrative environments. Managing these matters requires addressing the specific requirements of 2 separate art units. The lack of concentration, with only 1 pending action per examiner, suggests a diverse but small-scale prosecution effort within the biotechnology field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIPPOLIS, ALEXANDRA ROSE | 1 | 46.9% | +59.0% |
| VIGIL, TORIANA NICHOLE | 1 | 53.1% | +24.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18553624 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | LIPPOLIS, ALEXANDRA ROSE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18553624 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | LIPPOLIS, ALEXANDRA ROSE | — |
| 17917365 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | VIGIL, TORIANA NICHOLE | — |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18553624 | DENDRITIC ARCHITECTURES AS NONVIRAL VECTORS IN GENE DELIVERY | LIPPOLIS, ALEXANDRA ROSE | 1637 | §102§103 | Non-Final OA | — | Pending | Oct 02, 2023 |
| 17917365 | CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY | VIGIL, TORIANA NICHOLE | 1612 | §103 | Non-Final OA | — | Pending | Oct 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial